Publications

Xia, M; Huang, P; Vago, F; Jiang, W; Tan, M. Pseudovirus Nanoparticles Displaying Plasmodium Circumsporozoite Proteins Elicited High Titers of Sporozoite-Binding Antibody. Vaccines. 2023; 11(11).

Xia, M; López, K; Vago, FS; Huang, P; Auguste, DI; Jiang, W; Auguste, AJ; Tan, M. A bioengineered pseudovirus nanoparticle displaying SARS-CoV 2 RBD fully protects mice from mortality and weight loss caused by SARS-CoV 2 challenge. Biotechnology Journal. 2023; 18(10):e2300130.

Hensley, C; Nyblade, C; Zhou, P; Parreño, V; Ramesh, A; Frazier, A; Frazier, M; Garrison, S; Fantasia-Davis, A; Cai, R; Huang, P-W; Xia, M; Tan, M; Yuan, L. Combined Live Oral Priming and Intramuscular Boosting Regimen with Rotarix® and a Nanoparticle-Based Trivalent Rotavirus Vaccine Evaluated in Gnotobiotic Pig Models of G4P[6] and G1P[8] Human Rotavirus Infection. Vaccines. 2023; 11(5).

Kawagishi, T; Sánchez-Tacuba, L; Feng, N; Costantini, VP; Tan, M; Jiang, X; Green, KY; Vinjé, J; Ding, S; Greenberg, HB. Mucosal and systemic neutralizing antibodies to norovirus induced in infant mice orally inoculated with recombinant rotaviruses. Proceedings of the National Academy of Sciences of the United States of America. 2023; 120(9):e2214421120.

Xia, M; Vago, F; Han, L; Huang, P; Nguyen, L; Boons, G-J; Klassen, JS; Jiang, W; Tan, M. The αTSR Domain of Plasmodium Circumsporozoite Protein Bound Heparan Sulfates and Elicited High Titers of Sporozoite Binding Antibody After Displayed by Nanoparticles. International Journal of Nanomedicine. 2023; 18:3087-3107.

Nyblade, C; Hensley, C; Parreño, V; Zhou, P; Frazier, M; Frazier, A; Ramesh, A; Lei, S; Degiuseppe, JI; Tan, M; Yuan, L. A New Gnotobiotic Pig Model of P[6] Human Rotavirus Infection and Disease for Preclinical Evaluation of Rotavirus Vaccines. Viruses. 2022; 14(12).

Rakau, K; Gededzha, M; Peenze, I; Huang, P; Tan, M; Steele, AD; Seheri, LM. The Association between Symptomatic Rotavirus Infection and Histo-Blood Group Antigens in Young Children with Diarrhea in Pretoria, South Africa. Viruses. 2022; 14(12).

Rosario, C; Tan, M. Chlamydia trachomatis RsbU Phosphatase Activity Is Inhibited by the Enolase Product, Phosphoenolpyruvate. Journal of Bacteriology. 2022; 204(10):e0017822.

Wang, K; Sheehan, L; Ramirez, C; Densi, A; Rizvi, S; Ekka, R; Sütterlin, C; Tan, M. A Reverse Genetic Approach for Studying sRNAs in Chlamydia trachomatis. mBio. 2022; 13(4):e0086422.

Muñoz, KJ; Tan, M; Sütterlin, C. Differential Effects of Small Molecule Inhibitors on the Intracellular Chlamydia Infection. mBio. 2022; 13(4):e0107622.

Han, Q; Xue, Z; Tan, M; Wang, L; Chen, H; Zhang, R. Bovine natural antibody IgM inhibits the binding of human norovirus protruding domain to its HBGA receptors. FEBS Open Bio. 2022; 12(8):1489-1497.

Xia, M; Huang, P; Tan, M. A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response. Pharmaceutics. 2022; 14(8).

Wang, C; Kang, H; Tan, M; Cong, J; Su, D; Li, X; Chen, Y. Structural Insight into Terminal Galactose Recognition by Two Non-HBGA Binding GI.3 Noroviruses. Journal of Virology. 2022; 96(13):e0042022.

Ison, MG; Tan, M; Daud, A; Huang, P; Jiang, JX. Quantitative norovirus viral load is not affected by home storage of stool. Transplant Infectious Disease. 2022; 24(3):e13826.

Xia, M; Hoq, MR; Huang, P; Jiang, W; Jiang, X; Tan, M. Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity. Nano Research. 2022; 15(5):4181-4190.

Tan, M. Norovirus Vaccines: Current Clinical Development and Challenges. Pathogens. 2021; 10(12).

Jiang, X; Tan, M; Xia, M; Huang, P; Kennedy, MA. Intra-species sialic acid polymorphism in humans: a common niche for influenza and coronavirus pandemics? Emerging Microbes and Infections. 2021; 10(1):1191-1199.

Wang, K; Muñoz, KJ; Tan, M; Sütterlin, C. Chlamydia and HPV induce centrosome amplification in the host cell through additive mechanisms. Cellular Microbiology. 2021; 23(12):e13397.

Xu, S; Mcginnis, KR; Liu, Y; Huang, P; Tan, M; Stuckert, MR; Burnside, RE; Jacob, EG; Ni, S; Jiang, X; Kennedy, MA. Structural basis of P[II] rotavirus evolution and host ranges under selection of histo-blood group antigens. Proceedings of the National Academy of Sciences of the United States of America. 2021; 118(36).

Zhou, H-L; Chen, L-N; Wang, S-M; Tan, M; Qiu, C; Qiu, T-Y; Wang, X-Y. Prevalence and Evolution of Noroviruses between 1966 and 2019, Implications for Vaccine Design. Pathogens. 2021; 10(8).

Xue, Z; Han, Q; Huang, P; Jiang, X; Tan, M; Zhao, Y; Li, N; Zhang, R. Characterization of Functional Components in Bovine Colostrum That Inhibit Norovirus Capsid Protruding Domains Interacting with HBGA Ligands. Pathogens. 2021; 10(7).

Muñoz, KJ; Wang, K; Sheehan, LM; Tan, M; Sütterlin, C. The Small Molecule H89 Inhibits Chlamydia Inclusion Growth and Production of Infectious Progeny. Infection and Immunity. 2021; 89(7):e0072920.

Wang, J-X; Chen, L-N; Zhang, C-J; Zhou, H-L; Zhang, Y-H; Zhang, X-J; Hao, Z-Y; Qiu, C; Ma, J-C; Zhao, Y-L; Zhong, W; Tan, M; Jiang, X; Wang, S-M; Wang, X-Y. Genetic susceptibility to rotavirus infection in Chinese children: a population-based case-control study. Human Vaccines & Immunotherapeutics. 2021; 17(6):1803-1810.

Enciso, G; Sütterlin, C; Tan, M; Wan, FYM. Stochastic Chlamydia Dynamics and Optimal Spread. Bulletin of Mathematical Biology. 2021; 83(4):24.

Liu, C; Huang, P; Zhao, D; Xia, M; Zhong, W; Jiang, X; Tan, M. Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine. Vaccine. 2021; 39(2):263-271.

Xia, M; Huang, P; Jiang, X; Tan, M. A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses. Viruses. 2021; 13(1).